Ultragenyx Pharmaceutical reported $4.18M in Cost of Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 6.68M 1.48M
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
Alnylam Pharmaceuticals ALNY:US $ 32.66M 2.41M
Biocryst Pharmaceuticals BCRX:US $ 0.62M 0.27M
Biomarin Pharmaceutical BMRN:US $ 103.54M 23.52M
Bluebird Bio BLUE:US $ 19.7M 4.4M
Epizyme EPZM:US $ 2M 493K
Esperion Therapeutics ESPR:US $ 5.56M 3.76M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Insmed INSM:US $ 10.18M 654K
IONIS PHARMACEUT IONS:US $ 3M 0.04M
Karyopharm Therapeutics KPTI:US $ 589K 549K
Kyowa Hakko Kirin 4151:JP Y 22860M 4004M
MacroGenics MGNX:US 1.66M 1.64M
Moderna Inc MRNA:US 722M 28M
Neurocrine Biosciences NBIX:US $ 4.2M 1.1M
Ptc Therapeutics PTCT:US $ 6.54M 0.82M
Puma Biotechnology PBYI:US $ 10.28M 1.69M
Regeneron Pharmaceuticals REGN:US $ 453.2M 240.5M
Sarepta Therapeutics SRPT:US $ 23.44M 3.93M
Ultragenyx Pharmaceutical RARE:US $ 4.18M 1.04M
Vertex Pharmaceuticals VRTX:US $ 236.51M 8.54M